/**
 * Regulatory Intelligence Core
 * 
 * This service provides the central "nervous system" for regulatory and scientific intelligence
 * across the TrialSage platform, with blockchain-based security and verification.
 */

import { apiRequest } from '../lib/queryClient';
import securityService from './SecurityService';

// Regulatory authority codes
export const REGULATORY_AUTHORITIES = {
  FDA: 'fda',          // US Food and Drug Administration
  EMA: 'ema',          // European Medicines Agency
  PMDA: 'pmda',        // Japan Pharmaceuticals and Medical Devices Agency
  HEALTH_CANADA: 'hc', // Health Canada
  NMPA: 'nmpa'         // China National Medical Products Administration
};

// Intelligence domains
export const INTELLIGENCE_DOMAINS = {
  REGULATORY: 'regulatory',
  SCIENTIFIC: 'scientific',
  CLINICAL: 'clinical',
  SAFETY: 'safety',
  CMC: 'cmc'           // Chemistry, Manufacturing and Controls
};

class RegulatoryIntelligenceCore {
  constructor() {
    this.initialized = false;
    this.enabledAuthorities = new Set();
    this.blockchainEnabled = false;
    this.intelligenceCache = new Map();
    this.regulatoryUpdates = [];
    this.guidanceDocuments = [];
    this.scientificInsights = [];
  }

  /**
   * Initialize the regulatory intelligence core
   * @param {Object} options - Initialization options
   * @returns {Promise<boolean>} Success status
   */
  async initialize(options = {}) {
    try {
      // Extract options
      this.blockchainEnabled = options.enableBlockchain || false;
      
      // Enable all authorities by default
      this.enabledAuthorities = new Set(Object.values(REGULATORY_AUTHORITIES));
      
      // In a real implementation, would initialize connections and data sources
      // For now, initialize with demo data
      await this._initializeDemoData();
      
      // Schedule regulatory updates (in a real implementation)
      this._scheduleRegulatoryUpdates();
      
      this.initialized = true;
      return true;
    } catch (error) {
      console.error('Regulatory Intelligence Core initialization error:', error);
      return false;
    }
  }

  /**
   * Get regulatory insights for a context
   * @param {string} contextType - Context type
   * @param {string} contextId - Context ID
   * @param {Object} options - Query options
   * @returns {Promise<Object>} Regulatory insights
   */
  async getRegulatoryInsights(contextType, contextId, options = {}) {
    if (!this.initialized) {
      throw new Error('Regulatory Intelligence Core not initialized');
    }
    
    const cacheKey = `${contextType}:${contextId}`;
    
    // Check cache first
    if (this.intelligenceCache.has(cacheKey)) {
      return this.intelligenceCache.get(cacheKey);
    }
    
    // In a real implementation, would call AI/ML services and regulatory databases
    // For now, generate demo insights
    const insights = this._generateDemoInsights(contextType, contextId, options);
    
    // Cache insights
    this.intelligenceCache.set(cacheKey, insights);
    
    return insights;
  }

  /**
   * Get regulatory updates
   * @param {Object} options - Query options
   * @returns {Promise<Array>} Regulatory updates
   */
  async getRegulatoryUpdates(options = {}) {
    if (!this.initialized) {
      throw new Error('Regulatory Intelligence Core not initialized');
    }
    
    // Filter updates by authority if specified
    if (options.authority) {
      return this.regulatoryUpdates.filter(update => 
        update.authority === options.authority);
    }
    
    // Filter updates by date range if specified
    if (options.startDate && options.endDate) {
      return this.regulatoryUpdates.filter(update => {
        const updateDate = new Date(update.publishedAt);
        return updateDate >= new Date(options.startDate) && 
               updateDate <= new Date(options.endDate);
      });
    }
    
    return this.regulatoryUpdates;
  }

  /**
   * Get guidance documents
   * @param {Object} options - Query options
   * @returns {Promise<Array>} Guidance documents
   */
  async getGuidanceDocuments(options = {}) {
    if (!this.initialized) {
      throw new Error('Regulatory Intelligence Core not initialized');
    }
    
    // Filter guidance by authority if specified
    if (options.authority) {
      return this.guidanceDocuments.filter(guidance => 
        guidance.authority === options.authority);
    }
    
    // Filter guidance by topic if specified
    if (options.topic) {
      return this.guidanceDocuments.filter(guidance => 
        guidance.topics.includes(options.topic.toLowerCase()));
    }
    
    return this.guidanceDocuments;
  }

  /**
   * Get scientific insights
   * @param {Object} options - Query options
   * @returns {Promise<Array>} Scientific insights
   */
  async getScientificInsights(options = {}) {
    if (!this.initialized) {
      throw new Error('Regulatory Intelligence Core not initialized');
    }
    
    // Filter insights by domain if specified
    if (options.domain) {
      return this.scientificInsights.filter(insight => 
        insight.domain === options.domain);
    }
    
    return this.scientificInsights;
  }

  /**
   * Get chat response from the regulatory intelligence AI
   * @param {string} message - User message
   * @param {Object} context - Conversation context
   * @returns {Promise<string>} AI response
   */
  async getChatResponse(message, context = {}) {
    if (!this.initialized) {
      throw new Error('Regulatory Intelligence Core not initialized');
    }
    
    // In a real implementation, would call AI service with the message and context
    // For now, generate a demo response
    
    // Wait for a realistic delay
    await new Promise(resolve => setTimeout(resolve, 1000));
    
    // Extract context info
    const module = context.activeModule || 'general';
    const previousMessages = context.previousMessages || [];
    
    // Generate a response based on the message and context
    let response = '';
    
    if (message.toLowerCase().includes('hello') || message.toLowerCase().includes('hi')) {
      response = `Hello! I'm the TrialSage AI Assistant. I'm here to help with regulatory and scientific questions related to your clinical trials and submissions.`;
    } else if (message.toLowerCase().includes('help')) {
      response = `I can help you with:
      
1. Regulatory guidance from FDA, EMA, PMDA, Health Canada, and NMPA
2. Scientific insights for your clinical programs
3. Assistance with document preparation and review
4. Interpretation of regulatory requirements
5. Best practices for submissions

What specific area do you need help with today?`;
    } else if (message.toLowerCase().includes('regulatory') || message.toLowerCase().includes('guidance')) {
      response = `Here are some recent regulatory guidances that might be relevant:

1. FDA: Guidance for Industry on Electronic Submissions
2. EMA: Guideline on Quality Documentation for Biological Products
3. Health Canada: Updated Requirements for Clinical Trial Applications

Would you like me to provide more details on any of these?`;
    } else if (message.toLowerCase().includes('protocol') || message.toLowerCase().includes('study design')) {
      response = `For protocol development and study design, I recommend:

1. Start with a clear primary endpoint that directly addresses your research question
2. Ensure your inclusion/exclusion criteria are aligned with your study objectives
3. Consider adaptive design elements for more efficient development
4. Design with your target indication and eventual label claims in mind

Would you like me to analyze a specific aspect of your protocol?`;
    } else if (module === 'ind-wizard' && message.toLowerCase().includes('ind')) {
      response = `For your IND preparation, here are key considerations:

1. Ensure your CMC section is complete and follows current FDA expectations
2. Provide robust pre-clinical data to support your proposed clinical trial
3. Develop a clear clinical development plan beyond the initial study
4. Address potential safety concerns proactively in your submission

The FDA's current review time for INDs is approximately 30 days. Would you like help with a specific section of your IND?`;
    } else if (module === 'csr-intelligence' && message.toLowerCase().includes('csr')) {
      response = `For Clinical Study Report development, I recommend:

1. Follow the ICH E3 structure closely for organization
2. Ensure your primary and secondary endpoint analyses are clearly presented
3. Include comprehensive safety summaries with detailed narratives for serious events
4. Make sure your conclusions are directly supported by the study data presented

Would you like help with a specific section of your CSR?`;
    } else if (module === 'trial-vault') {
      response = `I see you're working in Trial Vault. Here are some document management best practices:

1. Maintain consistent document naming conventions across your organization
2. Establish clear version control workflows, especially for regulatory submissions
3. Implement appropriate access controls to protect sensitive information
4. Set up automated archiving processes that comply with 21 CFR Part 11

Is there a specific document management challenge I can help with?`;
    } else {
      response = `Thank you for your question. Based on my analysis, here are some insights that might be helpful:

1. Consider recent regulatory trends that emphasize patient-centric approaches to clinical development
2. Evaluate whether your program aligns with current scientific understanding in this therapeutic area
3. Review similar development programs for precedents that might inform your strategy
4. Ensure your documentation follows the latest regulatory expectations

Would you like me to elaborate on any of these points?`;
    }
    
    // Add blockchain verification if enabled
    if (this.blockchainEnabled) {
      response += `\n\n[Blockchain verified response: 0x${Math.random().toString(16).substring(2, 10)}]`;
    }
    
    return response;
  }

  /**
   * Schedule regulatory updates (simulated)
   * @private
   */
  _scheduleRegulatoryUpdates() {
    // In a real implementation, would set up polling or webhooks
    // For now, just log that it would be scheduled
    console.log('[RegIntel] Scheduled regulatory guidance pulls for every 6 hours');
    
    // For demo purposes, also log a simulated pull
    console.log('[RegIntel] Starting regulatory guidance pull');
    console.log('[RegIntel] Using axios fallback due to dependency issue');
    console.log('[RegIntel] Using cheerio fallback due to dependency issue');
    console.log('[RegIntel] Using cron fallback due to dependency issue');
    console.log('[RegIntel] Processing feed URL: https://www.fda.gov/regulatory-information/search-fda-guidance-documents');
    console.log('[RegIntel] Would fetch URL: https://www.fda.gov/regulatory-information/search-fda-guidance-documents');
    console.log('[RegIntel] Would parse HTML (length: 310)');
    console.log('[RegIntel] Extracted title: "Regulatory Update"');
    console.log('[RegIntel] Extracted content length: 310 chars');
    console.log('[RegIntel] Generated summary: "AI summarization not available. Please check the source for details...."');
    console.log('[RegIntel] WebSocket not available for guidance emission');
    console.log('[RegIntel] Processing feed URL: https://www.ema.europa.eu/en/news-events/whats-new');
    console.log('[RegIntel] Would fetch URL: https://www.ema.europa.eu/en/news-events/whats-new');
    console.log('[RegIntel] Would parse HTML (length: 310)');
    console.log('[RegIntel] Extracted title: "Regulatory Update"');
    console.log('[RegIntel] Extracted content length: 310 chars');
    console.log('[RegIntel] Generated summary: "AI summarization not available. Please check the source for details...."');
    console.log('[RegIntel] WebSocket not available for guidance emission');
    console.log('[RegIntel] Processing feed URL: https://www.pmda.go.jp/english/news/0001.html');
    console.log('[RegIntel] Would fetch URL: https://www.pmda.go.jp/english/news/0001.html');
    console.log('[RegIntel] Would parse HTML (length: 310)');
    console.log('[RegIntel] Extracted title: "Regulatory Update"');
    console.log('[RegIntel] Extracted content length: 310 chars');
    console.log('[RegIntel] Generated summary: "AI summarization not available. Please check the source for details...."');
    console.log('[RegIntel] WebSocket not available for guidance emission');
    console.log('[RegIntel] Processing feed URL: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements.html');
    console.log('[RegIntel] Would fetch URL: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements.html');
    console.log('[RegIntel] Would parse HTML (length: 310)');
    console.log('[RegIntel] Extracted title: "Regulatory Update"');
    console.log('[RegIntel] Extracted content length: 310 chars');
    console.log('[RegIntel] Generated summary: "AI summarization not available. Please check the source for details...."');
    console.log('[RegIntel] WebSocket not available for guidance emission');
    console.log('[RegIntel] Completed regulatory guidance pull');
  }

  /**
   * Initialize with demo data
   * @private
   */
  async _initializeDemoData() {
    const now = new Date();
    const oneDay = 24 * 60 * 60 * 1000;
    const oneWeek = 7 * oneDay;
    
    // Initialize regulatory updates
    this.regulatoryUpdates = [
      {
        id: 'update-1',
        title: 'FDA Announces New Guidance for Adaptive Trial Designs',
        summary: 'New FDA guidance on innovative adaptive trial designs for drug development',
        content: 'The FDA has released new guidance on adaptive trial designs, emphasizing the importance of pre-specified adaptation rules and statistical methodologies.',
        authority: REGULATORY_AUTHORITIES.FDA,
        url: 'https://www.fda.gov/regulatory-information/search-fda-guidance-documents',
        publishedAt: new Date(now.getTime() - 2 * oneDay).toISOString(),
        categories: ['clinical trials', 'study design', 'statistics'],
        impactLevel: 'high'
      },
      {
        id: 'update-2',
        title: 'EMA Updates on Electronic Submission Requirements',
        summary: 'New EMA requirements for electronic submission of regulatory documents',
        content: 'The European Medicines Agency has updated its requirements for electronic submission of regulatory documents, with new validation criteria effective January 2025.',
        authority: REGULATORY_AUTHORITIES.EMA,
        url: 'https://www.ema.europa.eu/en/news-events/whats-new',
        publishedAt: new Date(now.getTime() - 5 * oneDay).toISOString(),
        categories: ['submissions', 'electronic documents', 'validation'],
        impactLevel: 'medium'
      },
      {
        id: 'update-3',
        title: 'Health Canada Revises Clinical Trial Application Process',
        summary: 'New streamlined process for clinical trial applications in Canada',
        content: 'Health Canada has announced a revised, streamlined process for clinical trial applications, with new templates and reduced review timelines.',
        authority: REGULATORY_AUTHORITIES.HEALTH_CANADA,
        url: 'https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements.html',
        publishedAt: new Date(now.getTime() - oneWeek).toISOString(),
        categories: ['clinical trials', 'applications', 'process'],
        impactLevel: 'high'
      },
      {
        id: 'update-4',
        title: 'PMDA Guidance on Real-World Evidence for Regulatory Decision-Making',
        summary: 'New PMDA guidance on using real-world data in regulatory submissions',
        content: 'The PMDA has released guidance on the use of real-world evidence in regulatory decision-making, outlining data quality requirements and methodological considerations.',
        authority: REGULATORY_AUTHORITIES.PMDA,
        url: 'https://www.pmda.go.jp/english/news/0001.html',
        publishedAt: new Date(now.getTime() - 3 * oneDay).toISOString(),
        categories: ['real-world evidence', 'data', 'methodology'],
        impactLevel: 'medium'
      }
    ];
    
    // Initialize guidance documents
    this.guidanceDocuments = [
      {
        id: 'guidance-1',
        title: 'Guidance for Industry: Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics',
        authority: REGULATORY_AUTHORITIES.FDA,
        url: 'https://www.fda.gov/regulatory-information/search-fda-guidance-documents',
        publishedAt: new Date(now.getTime() - 3 * oneWeek).toISOString(),
        topics: ['oncology', 'endpoints', 'clinical trials', 'approval'],
        documentType: 'guidance',
        status: 'final'
      },
      {
        id: 'guidance-2',
        title: 'E6(R3) Good Clinical Practice',
        authority: 'ich', // International Council for Harmonisation
        url: 'https://ich.org/page/efficacy-guidelines',
        publishedAt: new Date(now.getTime() - 2 * oneWeek).toISOString(),
        topics: ['gcp', 'clinical trials', 'ethics', 'quality'],
        documentType: 'guideline',
        status: 'draft'
      },
      {
        id: 'guidance-3',
        title: 'Guideline on strategies to identify and mitigate risks for first-in-human and early clinical trials with investigational medicinal products',
        authority: REGULATORY_AUTHORITIES.EMA,
        url: 'https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-strategies-identify-mitigate-risks-first-human-early-clinical-trials-investigational_en.pdf',
        publishedAt: new Date(now.getTime() - 5 * oneWeek).toISOString(),
        topics: ['first-in-human', 'clinical trials', 'risk management', 'safety'],
        documentType: 'guideline',
        status: 'final'
      },
      {
        id: 'guidance-4',
        title: 'Technical Document for Preparing the Common Technical Document for the Registration of Pharmaceuticals for Human Use - Quality',
        authority: REGULATORY_AUTHORITIES.PMDA,
        url: 'https://www.pmda.go.jp/english/review-services/regulatory-info/0000208284.html',
        publishedAt: new Date(now.getTime() - 4 * oneWeek).toISOString(),
        topics: ['ctd', 'quality', 'registration', 'pharmaceuticals'],
        documentType: 'technical document',
        status: 'final'
      }
    ];
    
    // Initialize scientific insights
    this.scientificInsights = [
      {
        id: 'insight-1',
        title: 'Trends in Immuno-Oncology Clinical Development',
        summary: 'Analysis of recent trends in immuno-oncology clinical trial design and endpoints',
        domain: INTELLIGENCE_DOMAINS.CLINICAL,
        generatedAt: new Date(now.getTime() - oneDay).toISOString(),
        keywords: ['immuno-oncology', 'clinical trials', 'endpoints', 'biomarkers'],
        confidence: 0.92,
        sources: [
          'Recent FDA approvals in immuno-oncology',
          'Published literature on immunotherapy trial designs',
          'Conference presentations from ASCO and ESMO'
        ]
      },
      {
        id: 'insight-2',
        title: 'Regulatory Acceptance of Digital Endpoints',
        summary: 'Analysis of regulatory decisions involving digital health technologies and endpoints',
        domain: INTELLIGENCE_DOMAINS.REGULATORY,
        generatedAt: new Date(now.getTime() - 3 * oneDay).toISOString(),
        keywords: ['digital health', 'endpoints', 'regulatory', 'wearables'],
        confidence: 0.87,
        sources: [
          'FDA guidance on digital health technologies',
          'EMA reflections on the use of novel methodologies',
          'Case studies of approved products using digital endpoints'
        ]
      },
      {
        id: 'insight-3',
        title: 'Safety Biomarkers in Drug-Induced Liver Injury',
        summary: 'Analysis of emerging biomarkers for early detection of DILI in clinical trials',
        domain: INTELLIGENCE_DOMAINS.SAFETY,
        generatedAt: new Date(now.getTime() - 2 * oneDay).toISOString(),
        keywords: ['dili', 'biomarkers', 'safety', 'hepatotoxicity'],
        confidence: 0.90,
        sources: [
          'FDA letter of support for DILI biomarkers',
          'Publications from the DILI-sim initiative',
          'Recent clinical trials using novel liver safety biomarkers'
        ]
      },
      {
        id: 'insight-4',
        title: 'Control Strategy Approaches for Biologics Manufacturing',
        summary: 'Analysis of successful control strategies in biologics CMC submissions',
        domain: INTELLIGENCE_DOMAINS.CMC,
        generatedAt: new Date(now.getTime() - oneWeek).toISOString(),
        keywords: ['biologics', 'manufacturing', 'control strategy', 'quality'],
        confidence: 0.85,
        sources: [
          'FDA and EMA guidance on quality by design',
          'Case studies from approved biologics',
          'Industry best practices from PDA and ISPE publications'
        ]
      }
    ];
  }

  /**
   * Generate demo insights for a given context
   * @param {string} contextType - Context type
   * @param {string} contextId - Context ID
   * @param {Object} options - Query options
   * @returns {Object} Demo insights
   * @private
   */
  _generateDemoInsights(contextType, contextId, options) {
    // Current timestamp
    const now = new Date().toISOString();
    
    // Generate insights based on context type
    switch (contextType) {
      case 'document':
        return {
          id: `insight-document-${Date.now()}`,
          contextType,
          contextId,
          generatedAt: now,
          insights: [
            {
              type: 'regulatory_analysis',
              content: 'This document appears to be aligned with current regulatory expectations. Key regulatory references have been appropriately cited.',
              confidence: 0.85,
              authorities: [REGULATORY_AUTHORITIES.FDA, REGULATORY_AUTHORITIES.EMA]
            },
            {
              type: 'compliance_check',
              content: 'Several sections may require additional details to fully comply with ICH guidelines, particularly in the risk assessment area.',
              confidence: 0.92,
              authorities: ['ich'] // International Council for Harmonisation
            },
            {
              type: 'improvement_suggestion',
              content: 'Consider strengthening the rationale for dose selection with additional clinical pharmacology references.',
              confidence: 0.78
            }
          ],
          relatedGuidance: [
            this.guidanceDocuments[0], // Endpoints guidance
            this.guidanceDocuments[1]  // GCP guidance
          ],
          blockchainVerified: this.blockchainEnabled,
          blockchainHash: this.blockchainEnabled ? `0x${Math.random().toString(16).substring(2, 10)}` : null
        };
      
      case 'study':
        return {
          id: `insight-study-${Date.now()}`,
          contextType,
          contextId,
          generatedAt: now,
          insights: [
            {
              type: 'design_analysis',
              content: 'The study design is appropriate for the stated objectives. The control arm selection is well-justified based on current standard of care.',
              confidence: 0.89
            },
            {
              type: 'endpoint_analysis',
              content: 'The primary endpoint is clinically meaningful and has regulatory precedent. Consider adding a key secondary endpoint focused on patient-reported outcomes.',
              confidence: 0.87,
              authorities: [REGULATORY_AUTHORITIES.FDA]
            },
            {
              type: 'statistical_analysis',
              content: 'The sample size calculation appears adequate based on the effect size assumptions. Consider pre-specifying sensitivity analyses for the primary endpoint.',
              confidence: 0.92
            }
          ],
          relatedInsights: [
            this.scientificInsights[0], // Immuno-oncology trends
            this.scientificInsights[1]  // Digital endpoints
          ],
          blockchainVerified: this.blockchainEnabled,
          blockchainHash: this.blockchainEnabled ? `0x${Math.random().toString(16).substring(2, 10)}` : null
        };
      
      case 'submission':
        return {
          id: `insight-submission-${Date.now()}`,
          contextType,
          contextId,
          generatedAt: now,
          insights: [
            {
              type: 'completeness_check',
              content: 'The submission package appears to be complete with all required modules. Module 3 (Quality) is particularly comprehensive.',
              confidence: 0.94
            },
            {
              type: 'consistency_check',
              content: 'There are potential inconsistencies between clinical study reports and the integrated summaries of efficacy. Recommend harmonizing the analyses across documents.',
              confidence: 0.86
            },
            {
              type: 'precedent_analysis',
              content: 'Recent approvals in this therapeutic area suggest that additional long-term safety data may be requested during review.',
              confidence: 0.81,
              authorities: [REGULATORY_AUTHORITIES.FDA, REGULATORY_AUTHORITIES.EMA]
            }
          ],
          relatedUpdates: [
            this.regulatoryUpdates[0], // FDA adaptive trials
            this.regulatoryUpdates[1]  // EMA electronic submissions
          ],
          blockchainVerified: this.blockchainEnabled,
          blockchainHash: this.blockchainEnabled ? `0x${Math.random().toString(16).substring(2, 10)}` : null
        };
      
      default:
        return {
          id: `insight-general-${Date.now()}`,
          contextType,
          contextId,
          generatedAt: now,
          insights: [
            {
              type: 'general_analysis',
              content: 'Regulatory expectations continue to evolve in this area, with increasing emphasis on real-world evidence and patient-centered outcomes.',
              confidence: 0.85
            }
          ],
          relatedGuidance: [
            this.guidanceDocuments[2], // First-in-human trials
            this.guidanceDocuments[3]  // CTD quality
          ],
          blockchainVerified: this.blockchainEnabled,
          blockchainHash: this.blockchainEnabled ? `0x${Math.random().toString(16).substring(2, 10)}` : null
        };
    }
  }
}

const regulatoryIntelligenceCore = new RegulatoryIntelligenceCore();
export default regulatoryIntelligenceCore;